BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Diagnosis
27 results:

  • 1. Mass Spectrometry-Based Proteomics of Epithelial Ovarian cancers: A Clinical Perspective.
    Qian L; Sun R; Xue Z; Guo T
    Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Peripancreatic paraganglioma: Lesson from a round table.
    Petrelli F; Fratini G; Sbrozzi-Vanni A; Giusti A; Manta R; Vignali C; Nesi G; Amorosi A; Cavazzana A; Arganini M; Ambrosio MR
    World J Gastroenterol; 2022 Jun; 28(21):2396-2402. PubMed ID: 35800185
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ang-Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors.
    Oliveira S; Pereira SS; Costa MM; Monteiro MP; Pignatelli D
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628389
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
    Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
    Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gene expression in the Angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study.
    Kinnen A; Klaschik S; Neumann C; Egger EK; Mustea A; Soehle M; Frede S; Velten M; Coburn M; Hilbert T
    Life Sci; 2021 Jun; 274():119345. PubMed ID: 33713666
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic cancer.
    Fan Y; Li T; Xu L; Kuang T
    Comput Math Methods Med; 2020; 2020():6138039. PubMed ID: 33062039
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
    Hao X; Jia Q; Yuan J; Shi X; Guo H; Gao J; Guo Y
    Int J Mol Med; 2020 Nov; 46(5):1862-1872. PubMed ID: 32901852
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic heterogeneity of indeterminate thyroid nodules assessed preoperatively with next-generation sequencing reflects the diversity of the final histopathologic diagnosis.
    Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Wrotkowska E; Janicka-Jedyńska M; Więckowska B; Gil L; Ziemnicka K; Ruchała M
    Pol Arch Intern Med; 2019 Nov; 129(11):761-769. PubMed ID: 31535668
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
    Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Axitinib in the Treatment of Head and Neck Malignancies.
    Swiecicki PL; Spector M; Worden FP
    Curr Clin Pharmacol; 2016; 11(2):72-6. PubMed ID: 27188575
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of high-affinity vegfr3-binding peptides through a phage-displayed random peptide library.
    Shi LF; Wu Y; Li CY
    J Gynecol Oncol; 2015 Oct; 26(4):327-35. PubMed ID: 26197772
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Angiogenesis in primary hyperparathyroidism.
    Segiet OA; Michalski M; Brzozowa-Zasada M; Piecuch A; Żaba M; Helewski K; Gabriel A; Wojnicz R
    Ann Diagn Pathol; 2015 Apr; 19(2):91-8. PubMed ID: 25648902
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Value of VEGF-C, VEGF-D and vegfr-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma].
    Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum angiopoietin-2 and soluble vegfr-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.
    Sallinen H; Heikura T; Koponen J; Kosma VM; Heinonen S; Ylä-Herttuala S; Anttila M
    BMC Cancer; 2014 Sep; 14():696. PubMed ID: 25245329
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
    Liu JF; Barry WT; Birrer M; Lee JM; Buckanovich RJ; Fleming GF; Rimel B; Buss MK; Nattam S; Hurteau J; Luo W; Quy P; Whalen C; Obermayer L; Lee H; Winer EP; Kohn EC; Ivy SP; Matulonis UA
    Lancet Oncol; 2014 Oct; 15(11):1207-14. PubMed ID: 25218906
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Roles of serum and biliary CEA, CA19-9, vegfr3, and TAC in differentiating between malignant and benign biliary obstructions.
    Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
    Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
    Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
    Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.
    Ferreira CV; Siqueira DR; Romitti M; Ceolin L; Brasil BA; Meurer L; Capp C; Maia AL
    Int J Mol Sci; 2014 Mar; 15(4):5323-36. PubMed ID: 24675699
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
    Vecchione A; Belletti B; Lovat F; Volinia S; Chiappetta G; Giglio S; Sonego M; Cirombella R; Onesti EC; Pellegrini P; Califano D; Pignata S; Losito S; Canzonieri V; Sorio R; Alder H; Wernicke D; Stoppacciaro A; Baldassarre G; Croce CM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9845-50. PubMed ID: 23697367
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Biomarkers of parathyroid carcinoma.
    Erovic BM; Harris L; Jamali M; Goldstein DP; Irish JC; Asa SL; Mete O
    Endocr Pathol; 2012 Dec; 23(4):221-31. PubMed ID: 23001705
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.